<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-043835</identifier>
<setSpec>0210-0010</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Sleep apnea syndrome: short-term solutions and long-term cerebrovascular risk</dc:title>
<dc:description xml:lang="en">Introduction and development. During sleep, control of breathing shifts from being a semi-voluntary action tobecome a self-regulation activity of the highest biological priority. The most frequent breathing disorders during sleep arerelated to obstructive apnea syndrome, generally associated to snoring. The prevalence of sleep apnea (apnea-hypopnea) inthe general population has been estimated to be between 2% in females and 4% in males. Sleep apnea raises arterial pressure,increases the risk of cardiovascular and cerebrovascular disease, causes excessive sleepiness and diminishes the quality of lifeof patients affected by it. Conclusions. Polysomnography allows sleep apnea to be diagnosed so that treatment can then bestarted using continuous positive airway pressure (CPAP) devices, which is the most effective and widespread form oftreatment. There is a growing body of evidence to suggest that sustained treatment of sleep apnea lowers the risk of vascularcomplications, as well as improving the quality of life and reducing daytime sleepiness</dc:description>
<dc:creator>Culebras, A</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Introducción y desarrollo. Durante el sueño, el controlde la respiración pasa de ser un acto semivoluntario a convertirseen una actividad de autorregulación de máxima prioridad biológica.Los trastornos respiratorios del sueño se centran en el síndromede apnea obstructiva generalmente asociado a roncopatía. Laprevalencia de la apnea del sueño (apnea-hipopnea) en la poblacióngeneral se ha fijado entre el 2% en mujeres y el 4% en hombres.La apnea del sueño eleva la presión arterial, aumenta el riesgode enfermedad cardiovascular y cerebrovascular, causa somnolenciaexcesiva y disminuye la calidad de vida de los pacientes quela sufren. Conclusiones. La polisomnografía permite el diagnósticode apnea del sueño y da paso al tratamiento con aparatos de presiónpositiva de la vía aérea (CPAP), que es el método mas eficaz ygeneralizado de tratamiento. Existe evidencia creciente de que eltratamiento sostenido de la apnea del sueño disminuye el riesgo decomplicaciones vasculares, además de mejorar la calidad de vida ydisminuir la somnolencia diurna</dc:description>
<dc:source>Rev Neurol;42(1): 34-41, ene. 2006. ilus, tab</dc:source>
<dc:identifier>ibc-043835</dc:identifier>
<dc:title xml:lang="es">Síndrome de apnea del sueño: soluciones a corto plazo y riesgo cerebrovascular a largo plazo</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d13273^s22032</dc:subject>
<dc:subject>^d28612</dc:subject>
<dc:subject>^d13273^s22067</dc:subject>
<dc:subject>^d13273^s22012</dc:subject>
<dc:subject>^d13294^s22012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d7152^s22012</dc:subject>
<dc:subject>^d13273^s22016</dc:subject>
<dc:subject>^d9951^s22012</dc:subject>
<dc:subject>^d30611^s22074</dc:subject>
<dc:subject>^d12225</dc:subject>
<dc:subject>^d13273^s22080</dc:subject>
<dc:subject>^d34247^s22054</dc:subject>
<dc:subject>^d29278^s22045</dc:subject>
<dc:type>article</dc:type>
<dc:date>200601</dc:date>
</metadata>
</record>
</ibecs-document>
